In the News

55 News Items found
Ingrid Adams speaks with nurse practitioner Virginia Ferreira.
In the Clinic
Learn more about the new FDA-approved drug repotrectinib (AugtyroTM), which targets ROS1 fusions in lung cancer and other cancer types.
Dr. Alexander Drilon
The FDA has approved the targeted drug repotrectinib for patients 12 and older with tumors that carry gene changes called NTRK fusions. The trial that resulted in the approval was led by MSK investigators.
coffee cup surrounded by beans
Ask the Expert
Recent studies have raised the possibility that coffee might protect against colorectal cancer. MSK surgeon Garrett Nash advises against jumping to conclusions.
Two doctors looking at a patient
Q&A
MSK radiation therapy experts set the record straight about the safety of this effective treatment.
Table with Thanksgiving dinner
Learn how to make guests with cancer feel welcome and included at the table this holiday season.
Photo of an array of high-protein foods, including meat, cheese, milk, and nuts.
Support
Learn how to eat right and stay at a healthy weight by following these tips from MSK experts on diet and nutrition.
A man in his 70s (prostate cancer patient) smiling for camera
A new technology shows great promise for imaging and treating advanced forms of prostate cancer.
Man in his 70s (prostate cancer patient) smiling for camera
A new treatment that selectively seeks out prostate cancer cells shows great promise for treating advanced forms of the disease.
Dermatologist Ashfaq Marghoob
Feature
5 Surprising Facts about Melanoma
Expand your knowledge of melanoma with these surprising facts.
Christina and Kevin walk down stairs. Christina is wearing a blue dress and carrying a bouquet. Kevin is wearing a tuxedo.
The FDA has approved the targeted therapy datopotamab deruxtecan (Datroway® or Dato-DXd) for triple-negative breast cancer based on clinical research led by MSK.